JPS52130922U - - Google Patents

Info

Publication number
JPS52130922U
JPS52130922U JP4000176U JP4000176U JPS52130922U JP S52130922 U JPS52130922 U JP S52130922U JP 4000176 U JP4000176 U JP 4000176U JP 4000176 U JP4000176 U JP 4000176U JP S52130922 U JPS52130922 U JP S52130922U
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4000176U
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP4000176U priority Critical patent/JPS52130922U/ja
Publication of JPS52130922U publication Critical patent/JPS52130922U/ja
Pending legal-status Critical Current

Links

JP4000176U 1976-03-31 1976-03-31 Pending JPS52130922U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4000176U JPS52130922U (en) 1976-03-31 1976-03-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4000176U JPS52130922U (en) 1976-03-31 1976-03-31

Publications (1)

Publication Number Publication Date
JPS52130922U true JPS52130922U (en) 1977-10-05

Family

ID=28499151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4000176U Pending JPS52130922U (en) 1976-03-31 1976-03-31

Country Status (1)

Country Link
JP (1) JPS52130922U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9447006B2 (en) 2005-06-01 2016-09-20 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9447006B2 (en) 2005-06-01 2016-09-20 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Similar Documents

Publication Publication Date Title
FR2363220B1 (en)
CS190860B1 (en)
CS177778B1 (en)
CS184613B1 (en)
CH601904A5 (en)
BG23293A1 (en)
BG23452A1 (en)
CH580766A5 (en)
CH587375A5 (en)
CH592967A5 (en)
CH594105A5 (en)
CH594892A5 (en)
CH595005A5 (en)
CH595170A5 (en)
CH597659A5 (en)
CH598450A5 (en)
CH598497A5 (en)
CH598905A5 (en)
CH598937A5 (en)
CH599781A5 (en)
CH600316A5 (en)
CH600358A5 (en)
CH600671A5 (en)
CH600682A5 (en)
CH601483A5 (en)